© 1995 Oxford University Press
research-article |
Self-reported Functioning and Well-being in Patients with Parkinson's Disease: Comparison of the Short-form Health Survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39)
1Health Services Research Unit
2Department of Public Health and Primary Care, University of Oxford
3Department of Neurology, Radcliffe Infirmary Oxford OX2 6HE
The purpose of this paper was to document the impact of Parkinson's disease (PD) upon patients using both a generic health status measure (the Short-form 36 health survey questionnaire, SF-36) and a disease-specific measure (the 39-item Parkinson's Disease Questionnaire, PDQ-39). Comparing the results of the SF-36 in this population with a similar aged group selected randomly from two general practices it was evident that the disease has considerable impact on general levels of functioning and well-being. Furthermore, other areas not contained on the SF-36 were found to be relevant to PD patients. It is suggested that the disease-specific measure will be of value, ideally alongside a generic measure, in studies aimed at determining the impact of a treatment régimen upon PD patients, or to monitor the long-term progress of cohorts of patients with PD. The paper highlights the need for careful consideration of measures for evaluation.
Received April 29, 1995;
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Montel, A.-M. Bonnet, and C. Bungener Quality of Life in Relation to Mood, Coping Strategies, and Dyskinesia in Parkinson's Disease J Geriatr Psychiatry Neurol, June 1, 2009; 22(2): 95 - 102. [Abstract] [PDF]
|
|
|
|
 |
|
 J Grace, M M Amick, and J H Friedman A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease J. Neurol. Neurosurg. Psychiatry, January 1, 2009; 80(1): 18 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Grosset, L Taurah, D J Burn, D MacMahon, A Forbes, K Turner, A Bowron, R Walker, L Findley, O Foster, et al. A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis J. Neurol. Neurosurg. Psychiatry, May 1, 2007; 78(5): 465 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.Y.H. Kim, R. G. Holloway, S. Frank, C. A. Beck, C. Zimmerman, R. Wilson, and K. Kieburtz Volunteering for early phase gene transfer research in Parkinson disease Neurology, April 11, 2006; 66(7): 1010 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wieler, R. Camicioli, C. A. Jones, and W. R. Wayne Martin Botulinum toxin injections do not improve freezing of gait in Parkinson disease Neurology, August 23, 2005; 65(4): 626 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Heffernan and C. Jenkinson Review Paper: Measuring outcomes for neurological disorders: a review of disease-specific health status instruments for three degenerative neurological conditions Chronic Illness, June 1, 2005; 1(2): 131 - 142. [Abstract] [PDF]
|
|
|
|
|
|
K. R. Chaudhuri and P. Martinez-Martin Clinical assessment of nocturnal disability in Parkinson's disease: The Parkinson's Disease Sleep Scale Neurology, October 26, 2004; 63(8_suppl_3): S17 - S20. [Full Text]
|
|
|
|
|
|
T H Haapaniemi, K A Sotaniemi, H Sintonen, and E Taimela The generic 15D instrument is valid and feasible for measuring health related quality of life in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, July 1, 2004; 75(7): 976 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Riazi, J C Hobart, D L Lamping, R Fitzpatrick, J A Freeman, C Jenkinson, V Peto, and A J Thompson Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles J. Neurol. Neurosurg. Psychiatry, June 1, 2003; 74(6): 710 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Jarman, B. Hurwitz, A. Cook, M. Bajekal, and A. Lee Effects of community based nurses specialising in Parkinson's disease on health outcome and costs: randomised controlled trial BMJ, May 4, 2002; 324(7345): 1072 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Hobart, L. S. Williams, K. Moran, and A. J. Thompson Quality of Life Measurement After Stroke: Uses and Abuses of the SF-36 Stroke, May 1, 2002; 33(5): 1348 - 1356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Marinus, C Ramaker, J J van Hilten, and A M Stiggelbout Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments J. Neurol. Neurosurg. Psychiatry, February 1, 2002; 72(2): 241 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Hobart, J Freeman, D Lamping, R Fitzpatrick, and A Thompson The SF-36 in multiple sclerosis: why basic assumptions must be tested J. Neurol. Neurosurg. Psychiatry, September 1, 2001; 71(3): 363 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Jenkinson, R Fitzpatrick, A Garratt, V Peto, and S Stewart-Brown Can item response theory reduce patient burden when measuring health status in neurological disorders? Results from Rasch analysis of the SF-36 physical functioning scale (PF-10) J. Neurol. Neurosurg. Psychiatry, August 1, 2001; 71(2): 220 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J P Hobson, N I Edwards, and R J Meara The Parkinson's Disease Activities of Daily Living Scale: a new simple and brief subjective measure of disability in Parkinson's disease Clinical Rehabilitation, March 1, 2001; 15(3): 241 - 246. [Abstract] [PDF]
|
|
|
|
|
|
A. G. Hamedani, C. K. Wells, L. M. Brass, W. N. Kernan, C. M. Viscoli, J. N. Maraire, I. A. Awad, and R. I. Horwitz A Quality-of-Life Instrument for Young Hemorrhagic Stroke Patients Stroke, March 1, 2001; 32(3): 687 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schrag, C. Selai, M. Jahanshahi, and N. P Quinn The EQ-5D---a generic quality of life measure---is a useful instrument to measure quality of life in patients with Parkinson's disease J. Neurol. Neurosurg. Psychiatry, July 1, 2000; 69(1): 67 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Bronstein, A. DeSalles, M. R. DeLong, and for the Workshop Participants Stereotactic Pallidotomy in the Treatment of Parkinson Disease: An Expert Opinion Arch Neurol, September 1, 1999; 56(9): 1064 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. BEN-SHLOMO Health outcome measures J. Neurol. Neurosurg. Psychiatry, April 1, 1999; 66(4): 416 - 416. [Full Text]
|
|
|
|
|
|
K. H. Karlsen, J. P Larsen, E. Tandberg, and J. G Mæland Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease J. Neurol. Neurosurg. Psychiatry, April 1, 1999; 66(4): 431 - 435. [Abstract] [Full Text]
|
|
|
|
 |
|
 U. Nanda and E. M. Andresen Health-Related Quality of Life: A Guide for the Health Professional Eval Health Prof, June 1, 1998; 21(2): 179 - 215. [Abstract] [PDF]
|
|
|
|
|
|
J Sitzia, V Haddrell, and M Rice-Oxley Evaluation of a nurse-led multidisciplinary neurological rehabilitation programme using the Nottingham Health Profile Clinical Rehabilitation, May 1, 1998; 12(5): 389 - 394. [Abstract] [PDF]
|
|
|
|
|
|
C. Anderson, S. Laubscher, and R. Burns Validation of the Short Form 36 (SF-36) Health Survey Questionnaire Among Stroke Patients Stroke, October 1, 1996; 27(10): 1812 - 1816. [Abstract] [Full Text]
|
|